Neogen Corporation (NEOG) Stock
Healthcare · Medical Devices · Member of Other US Stocks
Neogen Corporation (NEOG) closed at USD 12.13 on 2026-10-14, a change of +96.9 % over the past year, with a market capitalization of USD 2.68B.
Neogen Corporation recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 12.13 |
| 2026-10-13 | 11.73 |
| 2026-10-12 | 12.00 |
| 2026-10-09 | 11.85 |
| 2026-10-08 | 11.71 |
| 2026-10-07 | 11.68 |
| 2026-10-06 | 11.96 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Neogen Corporation key figures
- Previous close
- USD 12.13 (2026-10-14)
- 1-year change
- +96.9 %
- Market cap
- USD 2.68B
- Enterprise value
- USD 3.28B
- P/E ratio (trailing)
- -45.44
- P/E ratio (forward)
- 30.42
- EPS (trailing)
- -0.27
- EPS (forward)
- 0.40
- PEG ratio
- 0.66
- Price to book
- 1.28
- Revenue growth
- 6.5 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 2.85
- Employees
- 2,636
- Analyst consensus (third-party)
- buy
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Neogen Corporation
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis. The company has a strategic collaboration with Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Neogen Corporation and compare it with other stocks.
Analyze NEOGAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Neogen Corporation shares.